NewsRx

Search our medical news database

Abaxis, Inc.

Lyophilization technology licensed to Cepheid

Published in Healthcare Finance, Tax and Law Weekly, November 2nd, 2005

Abaxis, Inc., (ABAX) announced that it has completed an agreement to license a portion of its patent portfolio covering lyophilization technology to Cepheid (CPHD).

"Lyophilization is essentially the process of freeze-drying reagents in micro quantities," commented Clint Severson, chairman, president and CEO of Abaxis. "Our Orbos technology enables the effective manufacturing and lyophilization of reagents and is considered one of the most effective formats for reagent utilization in molecular diagnostics."

"This agreement with Cepheid brings to three the number of major companies that are utilizing our Orbos lyophilization technology. This includes...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook